11.42
price down icon2.64%   -0.31
after-market Dopo l'orario di chiusura: 11.42
loading
Precedente Chiudi:
$11.73
Aprire:
$11.71
Volume 24 ore:
84,957
Relative Volume:
0.86
Capitalizzazione di mercato:
$107.23M
Reddito:
-
Utile/perdita netta:
$-81.17M
Rapporto P/E:
-1.1269
EPS:
-10.1344
Flusso di cassa netto:
$-82.84M
1 W Prestazione:
-17.25%
1M Prestazione:
-31.49%
6M Prestazione:
-78.06%
1 anno Prestazione:
-77.27%
Intervallo 1D:
Value
$11.00
$11.98
Intervallo di 1 settimana:
Value
$11.00
$14.20
Portata 52W:
Value
$11.00
$98.00

Korro Bio Inc Stock (KRRO) Company Profile

Name
Nome
Korro Bio Inc
Name
Telefono
617-468-1999
Name
Indirizzo
60 FIRST STREET, CAMBRIDGE
Name
Dipendente
104
Name
Cinguettio
Name
Prossima data di guadagno
2024-12-08
Name
Ultimi documenti SEC
Name
KRRO's Discussions on Twitter

Confronta KRRO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
KRRO
Korro Bio Inc
11.42 129.59M 0 -81.17M -82.84M -10.13
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Korro Bio Inc Stock (KRRO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-29 Iniziato Cantor Fitzgerald Overweight
2025-04-16 Iniziato Chardan Capital Markets Buy
2025-01-10 Iniziato Oppenheimer Outperform
2024-10-21 Iniziato Raymond James Strong Buy
2024-08-14 Iniziato William Blair Outperform
2024-03-28 Reiterato H.C. Wainwright Buy
2024-02-27 Iniziato BMO Capital Markets Outperform
2023-12-04 Iniziato H.C. Wainwright Buy
2023-11-29 Iniziato RBC Capital Mkts Outperform
2023-11-10 Iniziato Piper Sandler Overweight
2023-02-15 Downgrade Chardan Capital Markets Buy → Neutral
2023-02-13 Downgrade Cowen Outperform → Market Perform
2021-09-22 Downgrade Goldman Buy → Neutral
2021-01-27 Aggiornamento JP Morgan Neutral → Overweight
2020-12-22 Iniziato B. Riley Securities Buy
2020-07-14 Iniziato Oppenheimer Outperform
2020-05-18 Downgrade JP Morgan Overweight → Neutral
2019-10-28 Iniziato Cowen Outperform
2019-10-28 Iniziato Goldman Buy
2019-10-28 Iniziato JP Morgan Overweight
Mostra tutto

Korro Bio Inc Borsa (KRRO) Ultime notizie

pulisher
May 28, 2025

Korro Bio, Inc. (NASDAQ:KRRO) Shares Purchased by BNP Paribas Financial Markets - Defense World

May 28, 2025
pulisher
May 27, 2025

Korro Bio’s SWOT analysis: RNA editing pioneer’s stock faces pivotal year By Investing.com - Investing.com South Africa

May 27, 2025
pulisher
May 27, 2025

Korro Bio’s SWOT analysis: RNA editing pioneer’s stock faces pivotal year - Investing.com Nigeria

May 27, 2025
pulisher
May 26, 2025

Korro Bio, Inc. (NASDAQ:KRRO) Stock Position Boosted by Northern Trust Corp - Defense World

May 26, 2025
pulisher
May 19, 2025

Brokers Offer Predictions for Korro Bio FY2025 Earnings - Defense World

May 19, 2025
pulisher
May 19, 2025

Balyasny Asset Management L.P. Makes New Investment in Korro Bio, Inc. (NASDAQ:KRRO) - Defense World

May 19, 2025
pulisher
May 14, 2025

Korro to Participate in Upcoming Investor Conferences - The Manila Times

May 14, 2025
pulisher
May 14, 2025

Korro Bio Leadership Takes Stage at Three Major Healthcare Conferences: RBC, Jefferies, and Goldman Sachs - Stock Titan

May 14, 2025
pulisher
May 14, 2025

Korro Bio (KRRO) Rating and Price Target Maintained by Chardan C - GuruFocus

May 14, 2025
pulisher
May 13, 2025

Oppenheimer Adjusts Price Target for Korro Bio (KRRO) Amid Secto - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Oppenheimer Lowers Price Target for Korro Bio (KRRO) But Maintai - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Oppenheimer Lowers Price Target for Korro Bio (KRRO) But Maintains Rating | KRRO Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Oppenheimer Adjusts Korro Bio Price Target to $90 From $155, Maintains Outperform Rating - marketscreener.com

May 13, 2025
pulisher
May 12, 2025

Korro Bio Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025
pulisher
May 12, 2025

Korro Bio FY2025 EPS Estimate Raised by Cantor Fitzgerald - Defense World

May 12, 2025
pulisher
May 12, 2025

Q2 Earnings Estimate for Korro Bio Issued By William Blair - Defense World

May 12, 2025
pulisher
May 12, 2025

Q2 Earnings Forecast for Korro Bio Issued By HC Wainwright - Defense World

May 12, 2025
pulisher
May 11, 2025

HC Wainwright Cuts Korro Bio (NASDAQ:KRRO) Price Target to $100.00 - Defense World

May 11, 2025
pulisher
May 11, 2025

HC Wainwright Comments on Korro Bio FY2026 Earnings - Defense World

May 11, 2025
pulisher
May 11, 2025

Wells Fargo & Company MN Raises Holdings in Korro Bio, Inc. (NASDAQ:KRRO) - Defense World

May 11, 2025
pulisher
May 10, 2025

10,384 Shares in Korro Bio, Inc. (NASDAQ:KRRO) Purchased by Barclays PLC - Defense World

May 10, 2025
pulisher
May 10, 2025

10,347 Shares in Korro Bio, Inc. (NASDAQ:KRRO) Acquired by Raymond James Financial Inc. - Defense World

May 10, 2025
pulisher
May 09, 2025

Korro Bio (KRRO) Price Target Cut Amid Strategic Adjustments | K - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Korro Bio price target lowered to $53 from $130 at H.C. Wainwright - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Korro Bio, Inc. (NASDAQ:KRRO) Given Average Rating of “Buy” by Analysts - Defense World

May 09, 2025
pulisher
May 09, 2025

Korro Bio Reports Q1 2025 Financial Results - TipRanks

May 09, 2025
pulisher
May 08, 2025

Korro Bio stock price target lowered to $100 at H.C. Wainwright By Investing.com - Investing.com South Africa

May 08, 2025
pulisher
May 08, 2025

Korro Bio stock price target lowered to $100 at H.C. Wainwright - Investing.com Nigeria

May 08, 2025
pulisher
May 08, 2025

4 more biotechs cut staff amid market tumult - BioPharma Dive

May 08, 2025
pulisher
May 08, 2025

ALX Oncology won’t seek approval for CD47 drug in gastric cancer; Korro Bio’s layoffs - Endpoints News

May 08, 2025
pulisher
May 08, 2025

Korro lays off 20% of staff to fund genetic med trials, Novo Nordisk partnership - Fierce Biotech

May 08, 2025
pulisher
May 08, 2025

Korro Bio (KRRO) Analyst Rating Update: Price Target Lowered | K - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Korro Bio (KRRO) Price Target Reduced, Buy Rating Maintained | K - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Korro Reports First Quarter 2025 Financial Results and Provides Business Updates - The Manila Times

May 08, 2025
pulisher
May 07, 2025

Korro (KRRO) Surpasses Q1 Revenue Expectations Amid Promising Cl - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Korro Bio Announces Strategic Workforce Reduction Plan - TipRanks

May 07, 2025
pulisher
May 07, 2025

Korro Bio, Inc. SEC 10-Q Report - TradingView

May 07, 2025
pulisher
May 07, 2025

Korro Bio, Inc. Reports Q1 2025 Financial Results and Updates on KRRO-110 Development for Alpha-1 Antitrypsin Deficiency - Nasdaq

May 07, 2025
pulisher
May 06, 2025

JPMorgan Chase & Co. Sells 9,537 Shares of Korro Bio, Inc. (NASDAQ:KRRO) - Defense World

May 06, 2025
pulisher
May 03, 2025

Legal & General Group Plc Raises Stock Holdings in Korro Bio, Inc. (NASDAQ:KRRO) - Defense World

May 03, 2025
pulisher
May 02, 2025

Analysts Offer Predictions for Korro Bio FY2025 Earnings - Defense World

May 02, 2025
pulisher
May 01, 2025

Cantor Fitzgerald Upgrades Korro Bio (NASDAQ:KRRO) to Strong-Buy - Defense World

May 01, 2025
pulisher
Apr 30, 2025

Cantor Fitzgerald sets $74 target on Korro Bio stock with Overweight rating - Investing.com India

Apr 30, 2025
pulisher
Apr 29, 2025

Korro Bio (KRRO) Receives Overweight Rating and $74 Price Target - GuruFocus

Apr 29, 2025
pulisher
Apr 29, 2025

Korro Bio (KRRO) Receives Overweight Rating and $74 Price Target | KRRO Stock News - GuruFocus

Apr 29, 2025
pulisher
Apr 19, 2025

Korro Bio (NASDAQ:KRRO) Research Coverage Started at Chardan Capital - Defense World

Apr 19, 2025
pulisher
Apr 16, 2025

Chardan sets $25 target on Korro Bio stock with Buy rating - Investing.com Australia

Apr 16, 2025
pulisher
Apr 16, 2025

Chardan Capital Initiates Coverage of Korro Bio (KRRO) with Buy Recommendation - Nasdaq

Apr 16, 2025
pulisher
Apr 16, 2025

Chardan Initiates Korro Bio at Buy With $25 Price Target - marketscreener.com

Apr 16, 2025
pulisher
Apr 15, 2025

Korro Bio, Inc. (NASDAQ:KRRO) Shares Bought by Wellington Management Group LLP - Defense World

Apr 15, 2025
pulisher
Apr 14, 2025

Korro Bio, Inc. (NASDAQ:KRRO) Given Consensus Rating of “Buy” by Brokerages - Defense World

Apr 14, 2025

Korro Bio Inc Azioni (KRRO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
Capitalizzazione:     |  Volume (24 ore):